Skip to main content
EVGN
NASDAQ Industrial Applications And Services

Evogene CFO Yaron Eldad Resigns; VP Finance Polina Ravzin to Assume Role

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$1.06
Mkt Cap
$9.241M
52W Low
$0.93
52W High
$2.42
52W Position info
14% above low
Off High info
56% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

EVGN is trading near its 52-week low of $0.93 (14% above the low) on light trading volume (0.4× avg).

Summary

Evogene Ltd. announced the resignation of its Chief Financial Officer, Yaron Eldad, effective March 31, 2026, with current VP Finance Polina Ravzin stepping into the CFO role.


Key Events · Executive and Board Changes · EVGN

  • CFO Resignation Announced

    Mr. Yaron Eldad, Evogene's Chief Financial Officer, notified his resignation from his position, effective March 31, 2026.

  • Successor Appointed Internally

    Ms. Polina Ravzin, the Company's current VP Finance, will assume the responsibilities of the CFO. Ms. Ravzin has served as VP Finance since 2022.

  • Reason for Departure

    The company stated that Mr. Eldad's resignation was due to personal reasons and not a result of any disagreement with the company's operations, policies, or practices.


Analysis · EVGN · Industrial Applications And Services

The resignation of a Chief Financial Officer is a notable event for any company, particularly for a micro-cap like Evogene Ltd. While the company stated the departure is for personal reasons and not due to disagreements, a change in financial leadership always introduces a degree of uncertainty. However, the immediate appointment of the current VP Finance, Polina Ravzin, as the successor provides a measure of continuity and suggests a planned transition, which helps mitigate potential negative market reactions. Investors will likely monitor the company's financial reporting and strategic direction under the new CFO.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, EVGN was trading at $1.06 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $9.2M. The 52-week trading range was $0.93 to $2.42. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

EVGN - Latest Insights

EVGN
Nov 19, 2026, 7:12 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.3233
Real-time Price: $0.310 info
Change: -$0.0133 (-4%) info
Market Cap: $5.651M info
EVGN
Nov 16, 2026, 7:01 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.3646
Real-time Price: $0.310 info
Change: -$0.0546 (-15%) info
Market Cap: $5.651M info
EVGN
Oct 06, 2026, 4:00 PM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $0.4101
Real-time Price: $0.310 info
Change: -$0.1001 (-24%) info
Market Cap: $5.651M info
EVGN
Sep 30, 2026, 7:15 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.4168
Real-time Price: $0.310 info
Change: -$0.1068 (-26%) info
Market Cap: $5.651M info
EVGN
Sep 28, 2026, 4:10 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.3907
Real-time Price: $0.310 info
Change: -$0.0807 (-21%) info
Market Cap: $5.651M info